Drugs / vanoxerine
vanoxerine
Trials 6
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 14 trials | ||||||
| Phase 1 | NCT00218049 | Dec 2004 → Jul 2005 | cocaine abuse, cocaine dependence | National Institute on Drug Abuse (NIDA) | Terminated | No outcome recorded |
| Phase 1 | NCT00100113 | Jun 2004 → Jun 2005 | substance-related disorder | National Institute on Drug Abuse (NIDA) | Unknown | No outcome recorded |
| Phase 1 | NCT00089687 | Apr 2004 → May 2005 | substance-related disorder | National Institute on Drug Abuse (NIDA) | Unknown | No outcome recorded |
| Phase 1 | NCT00051896 | Aug 2002 → ? | substance-related disorder | National Institute on Drug Abuse (NIDA) | Unknown | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT01691313 | Nov 2012 → Sep 2013 | atrial fibrillation, atrial flutter | Laguna Pharmaceuticals, Inc. | Completed | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT02454283 | Sep → Nov 2015 | atrial fibrillation | Laguna Pharmaceuticals, Inc. | Terminated | No outcome recorded |
Evidence & citations 6 cited values
Every value below carries the sentence it was read from. 8 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Vanoxerine | “Interaction Between Vanoxerine (GBR 12909) and Cocaine in Cocaine Dependent Individuals” NCT00218049 ↗ |
| Known as | GBR 12909 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00051896 ↗ |
| Known as | Vanoxerina | ChEMBL registry synonym — accepted as the source's own label CHEMBL281594 ↗ |
| Action | Inhibit | “The multi-ion channel blocker vanoxerine may prove an effective alternative.” PMID 25684233 ↗ Feb 2015 |
| Modality | Small molecule | “vanoxerine, a 1,4-dialkylpiperazine derivative” PMID 25684233 ↗ Feb 2015 |
| Route | Oral | “3 escalating oral doses of GBR 12909” NCT00100113 ↗ |